Skip to content

A researcher at the University of Sydney is sounding the alarm on the increasingly common use of so-called "smart drugs" among college students. Cognitive-enhancing drugs …

Published on

Well-known health economist Victor Fuchs, PhD, always has interesting things to say about health care reform efforts (see here and here). Now he's shared more …

The New York Times is previewing a fascinating story from its magazine called "The Women's Crusade," about the interaction between global poverty and the oppression …

Published on

A few weeks ago I wrote about the debate swirling around Francis Collins' nomination as NIH director. Some people expressed concerns that Collins' status as …

Published on

As a church-going scientist-turned-writer, I was on the fence about the recent nomination of geneticist Francis Collins to lead the National Institutes of Health. There's …

Published on

Stanford's Irving Weissman, MD, questions who's really in charge of our national embryonic stem cell research policy.

Stanford's Irving Weissman, MD, questions who's really in charge of our national embryonic stem cell research policy.

Published on

Has Douglas Elmemdorf, CBO director, put a nail into the coffin on the notion that the Congress could possibly have a legislative reform package ready …

Published on

Keith Humphreys, PhD, professor of psychiatry and behavioral science, is embarking on a new role this week - that of Senior Policy Advisor at the …

When I asked Stanford health-care economist Victor Fuchs back in 2005 what it would take to significantly reform the U.S. health-care system, he said nothing …

Victor Fuchs, PhD, one of the nation's foremost health economists, says a government-run plan will not solve the huge financial issues that plague health-care in …

Published on

The concept behind comparative effectiveness research seems simple enough. Researchers would compare two or more strategies for treating a specific illness and then determine which …